22 May 2018 - The House on Tuesday passed “right to try” legislation that would allow people with life-threatening illnesses to bypass the FDA to obtain experimental medications, ending a drawn-out battle over access to unapproved therapies.

President Trump is expected to quickly sign the measure, which was praised by supporters as a lifeline for desperate patients but denounced by scores of medical and consumer groups as unnecessary and dangerous.

The Senate passed the bill in August, and the House approved its own version in March. That version was less objectionable to the medical groups, but then the legislation got bogged down. With the White House demanding action, House leaders in recent days decided to short-circuit the process by taking up the Senate-passed bill. The vote was 250 to 169.

Read Washington Post article